Stocklytics Platform
Asset logo for symbol IMRX
Immuneering Corporation
IMRX49
$1.19arrow_drop_down0.83%-$0.01
Penny Stock
Asset logo for symbol IMRX
IMRX49

$1.19

arrow_drop_down0.83%
Key Stats
Open$1.19
Prev. Close$1.20
EPS-1.86
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$35.58M
PE Ratio-
LOWHIGH
Day Range1.12
1.20
52 Week Range1.05
10.99
Ratios
Revenue-
EBITDA Margin %-
EPS-1.86
Fundamentals
RPS-
Gross Profit-
Payout Ratio-
Industry average yield2.85%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

IMRXarrow_drop_down0.83%
US Healthcare Sectorarrow_drop_up0.25%
US Marketarrow_drop_down0.38%
warning
IMRX / Market
IMRX lose to the US Market which returned -0.38% over the last twenty four hours.
warning
IMRX / Healthcare Sector
IMRX lose to the US Healthcare sector which returned 0.25% over the last twenty four hours.

Immuneering Corporation (IMRX) Statistics

Immuneering Corporation (IMRX) is a biotechnology company that specializes in the development of innovative therapies for various diseases. The company focuses on harnessing the power of computational biology and machine learning to accelerate drug discovery and development processes. With its cutting-edge platform, Immuneering Corporation aims to revolutionize the field of precision medicine and improve patient outcomes.

When it comes to valuation metrics, Immuneering Corporation shows promising figures. The company has a strong enterprise value to EBITDA ratio, indicating its ability to generate earnings compared to its market value. Additionally, Immuneering Corporation has a healthy profit margin, demonstrating its efficiency in generating profits from its operations. These positive metrics reflect the company's sound financial health and potential for future growth.

add Immuneering Corporation to watchlist

Keep an eye on Immuneering Corporation

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
How has Immuneering Corporation (IMRX) stock's performance compared to its sector and the market over the past year?

Over the past year, Immuneering Corporation (IMRX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 23.68%, Immuneering Corporation has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 51.00%, it has fallen short of the market average. This comparison highlights Immuneering Corporation's performance relative to both its sector and the overall market over the last year.

help
What is the PE ratio of Immuneering Corporation (IMRX) stock?

The PE ratio for Immuneering Corporation (IMRX) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.

help
What is the EPS of Immuneering Corporation (IMRX) stock?

The Earnings Per Share (EPS) for Immuneering Corporation (IMRX), calculated on a diluted basis, is -$1.86. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

help
What is the operating margin of Immuneering Corporation (IMRX) stock?

The operating margin for Immuneering Corporation (IMRX) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

help
What is the EBITDA of Immuneering Corporation (IMRX) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Immuneering Corporation (IMRX) is -$58.69M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

help
How much debt does Immuneering Corporation (IMRX) have?

Immuneering Corporation (IMRX) has a total debt of $4.38M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$61.91M.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level